Response to neoadjuvant paclitaxel predicts survival in anaplastic thyroid carcinoma.
Yamazaki H, Sugino K, Katoh R, Matsuzu K, Masaki C, Akaishi J, Hames KY, Tomoda C, Suzuki A, Ohkuwa K, Kitagawa W, Nagahama M, Rino Y, Ito K.
Yamazaki H, et al. Among authors: hames ky.
Cancer Med. 2023 Feb;12(3):3027-3035. doi: 10.1002/cam4.5219. Epub 2022 Sep 2.
Cancer Med. 2023.
PMID: 36052510
Free PMC article.